[1]
“Angiotensin Converting Enzyme Inhibitors, A Risk Factor of Poor Outcome in Diabetic Patients with COVID-19 Infection”,
IJKD, vol. 14, no. 6, pp. 482–487, Dec. 2020, Accessed: May 01, 2025. [Online]. Available:
https://ijkd.org/index.php/ijkd/article/view/5920